Oral News and Research

RSS

RedHill Biopharma initiates phase II study of BEKINDA for irritable bowel syndrome

RedHill Biopharma Ltd. (NASDAQ; RDHL) (TASE: RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced that it has initiated a randomized, double-blind, 2-arm parallel group Phase II clinical study in the U.S. evaluating the safety and efficacy of BEKINDA™ 12 mg in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).

13 Apr 2016

Novel antibiotics to overcome antibacterial resistance

Small and innovative pharmaceutical companies, with products in early stages of development, presented some of their novel approaches and antimicrobial therapies under development during a dedicated session at the annual congress (ECCMID) of the European Society of Clinical Microbiology and Infectious Diseases(ESCMID) in Amsterdam.

13 Apr 2016

New plant-derived oral drug can prevent progression of multiple sclerosis

An international research team has demonstrated that a new plant-derived drug can block the progression of multiple sclerosis (MS).

12 Apr 2016

Pooled analysis from seven clinical studies demonstrates consistent efficacy for ceftazidime-avibactam in the treatment of multi-drug resistant gram-negative bacteria

AstraZeneca has presented positive data demonstrating the efficacy of the investigational antibiotic, ceftazidime-avibactam (CAZ-AVI), in treating patients with ceftazidime-resistant Gram-negative infections, which are increasingly resistant to most available antibiotics, often precipitating the need for clinicians to reach for agents previously reserved for last-line use.

12 Apr 2016

AstraZeneca, MedImmune to present new clinical trial and scientific data on lung cancer treatments at ELCC 2016

AstraZeneca and its global biologics research and development arm, MedImmune, will report new clinical trial and scientific data from their industry-leading lung cancer franchise of marketed and pipeline medicines at the European Lung Cancer Conference in Geneva, Switzerland, 13 -16 April 2016.

11 Apr 2016

Phenotypic personalized medicine can identify a person's optimal drug, dose combinations

For decades, doctors and scientists have predicted that personalized medicine — tailoring drug doses and combinations to people's specific diseases and body chemistry — would be the future of health care.

7 Apr 2016

Oventus gains FDA clearance for medical device designed to alleviate snoring, OSA

Australian medical device company, Oventus Medical Ltd., has received clearance from the U.S. Food and Drug Administration for the O2VENT device, an oral appliance intended to reduce or alleviate snoring and mild to moderate obstructive sleep apnoea.

7 Apr 2016

Award-winning vitamin D oral spray could help improve heart function

Relief from low vitamin D levels could now be just a spray away thanks to an award-winning vitamin D oral spray that could help boost the vitamin D levels of those with chronic heart failure, resulting in improved heart function, according to a recent study.

From BetterYou Ltd 6 Apr 2016

Inhalable form of Ambrisentan drug could offer faster-acting treatment option for pulmonary edema

In a new study, researchers show an aerosolized, inhalable form of the drug Ambrisentan could offer a faster-acting treatment option for pulmonary edema, a life-threatening condition in which fluid accumulates in the lungs. Pulmonary edema is a significant risk for anyone spending time at high altitudes, and also affects people with chronic conditions including congestive heart failure and sickle cell anemia.

5 Apr 2016

Combining aromatase inhibitors with growth hormone may help short adolescent boys grow taller

Aromatase inhibitors, when used for up to three years in combination with growth hormone, may effectively and safely help very short adolescent boys grow taller, new research suggests. The study results will be presented Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society in Boston.

4 Apr 2016

Oral Salmonella-based vaccine could prevent Type 1 diabetes

A combined vaccine therapy including live Salmonella is a safe and effective way to prevent diabetes in mice and may point to future human therapies, a new study finds. The results will be on Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.

4 Apr 2016

Researchers compare lipid-lowering efficacy for two nonstatin therapies in statin-intolerant patients

Steven E. Nissen, M.D., of the Cleveland Clinic, and colleagues identified patients with muscle-related adverse effects from statins and compared lipid-lowering efficacy for two nonstatin therapies, ezetimibe and evolocumab. The study was published online by JAMA, and is being released to coincide with its presentation at the American College of Cardiology's 65th Annual Scientific Session & Expo.

4 Apr 2016

One in 10 people in UK believed to be vitamin B12 deficient

One in 10 people in the UK are believed to be deficient in vitamin B12 – that’s an astonishing six million people suffering from the consequences of having less than the optimum amount of B12 in their system.

From BetterYou Ltd 4 Apr 2016

Better oral hygiene, regular dental visits could slow down cognitive decline in older adults

Better oral hygiene and regular dental visits may play a role in slowing cognitive decline as people age, although evidence is not definitive enough to suggest that one causes the other.

2 Apr 2016

Study finds correlation between male sex hormones and oral health

More than 20 species of macaques, the most widely distributed nonhuman primates in the world, socialize in lively troops and make frequent appearances on National Geographic documentaries. But, what can we learn from one of our closest primate relatives about our own oral health?

31 Mar 2016

Naltrexone injections could reduce risk of relapse among opioid dependent individuals

In a multicenter, randomized clinical trial, ex-prisoners who received six monthly injections of naltrexone--a long-acting medication that blocks opioid receptors in the brain--were significantly less likely to resume opioid use than those who received counseling and referrals to community treatment centers without naltrexone.

31 Mar 2016

UCJC study reveals excessive electrolyte loss may lead to hyponatraemia

Spanish researchers have analysed how the sodium lost through sweat during a marathon influences the maintenance of stable and physiologically sound conditions that allow the body to carry out its functions. Excessive electrolyte loss may lead to a medical problem known as hyponatraemia.

31 Mar 2016

BodyGuard wearable patch product shows superiority to common NSAID treatments in restoring joint function

Perth skin science technology company OBJ Limited is set to revolutionise treatment of joint injuries and osteoarthritis after its BodyGuard wearable patch product proved its superiority to the world-leading non-steroidal anti-inflammatory drug product Voltaren.

31 Mar 2016

Abstracts on colistin resistance and migrant health part of 300 late-breaker sessions for ECCMID 2016

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores risks, knowledge sharing and best practices in the fight against infectious disease – has received more than 300 late-breaker abstract submissions for its annual congress, ECCMID 2016 in Amsterdam.

31 Mar 2016

Certain types of hormonal contraceptives may increase risk of seizures in women with epilepsy

Could certain types of hormonal contraceptives cause an increase in seizures in women with epilepsy? A recent Texas A&M Health Science Center study suggests that ethinyl estradiol, the primary component of oral contraceptives, could be detrimental to the epileptic brain.

30 Mar 2016

Oral News and Research

RedHill Biopharma initiates phase II study of BEKINDA for irritable bowel syndrome

Novel antibiotics to overcome antibacterial resistance

New plant-derived oral drug can prevent progression of multiple sclerosis

Pooled analysis from seven clinical studies demonstrates consistent efficacy for ceftazidime-avibactam in the treatment of multi-drug resistant gram-negative bacteria

AstraZeneca, MedImmune to present new clinical trial and scientific data on lung cancer treatments at ELCC 2016

Phenotypic personalized medicine can identify a person's optimal drug, dose combinations

Oventus gains FDA clearance for medical device designed to alleviate snoring, OSA

Award-winning vitamin D oral spray could help improve heart function

Inhalable form of Ambrisentan drug could offer faster-acting treatment option for pulmonary edema

Combining aromatase inhibitors with growth hormone may help short adolescent boys grow taller

Oral Salmonella-based vaccine could prevent Type 1 diabetes

Researchers compare lipid-lowering efficacy for two nonstatin therapies in statin-intolerant patients

One in 10 people in UK believed to be vitamin B12 deficient

Better oral hygiene, regular dental visits could slow down cognitive decline in older adults

Study finds correlation between male sex hormones and oral health

Naltrexone injections could reduce risk of relapse among opioid dependent individuals

UCJC study reveals excessive electrolyte loss may lead to hyponatraemia

BodyGuard wearable patch product shows superiority to common NSAID treatments in restoring joint function

Abstracts on colistin resistance and migrant health part of 300 late-breaker sessions for ECCMID 2016

Certain types of hormonal contraceptives may increase risk of seizures in women with epilepsy

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News